Source:http://linkedlifedata.com/resource/pubmed/id/18835982
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-22
|
pubmed:abstractText |
Vanillin has been reported to exhibit anti-invasive and antimetastatic activities by suppressing the enzymatic activity of matrix metalloproteinase-9 (MMP-9). However, the underlying mechanism of anti-invasive activity remains unclear so far. Herein we demonstrate that vanillin reduced 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced MMP-9 gelatinolytic activity and suppressed cell invasion through the down-regulation of MMP-9 gene transcription in HepG2 cells. Vanillin significantly reduced the 6.6-fold invasive capacity of HepG2 cells in noncytotoxic concentrations, and this anti-invasive effect was concentration-dependent in the Matrigel invasion assay. Moreover, vanillin significantly suppressed the TPA-induced enzymatic activity of MMP-9 and decreased the induced mRNA level of MMP-9. Analysis of the transcriptional regulation indicated that vanillin suppressed MMP-9 transcription by inhibiting nuclear factor-kappaB (NF-kappaB) activity. Western blot further confirmed that vanillin inhibited NF-kappaB activity through the inhibition of IkappaB-alpha phosphorylation and degradation. In conclusion, vanillin might be a potent antiinvasive agent that suppresses the MMP-9 enzymatic activity via NF-kappaB signaling pathway.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzaldehydes,
http://linkedlifedata.com/resource/pubmed/chemical/Formazans,
http://linkedlifedata.com/resource/pubmed/chemical/Luciferases,
http://linkedlifedata.com/resource/pubmed/chemical/MTT formazan,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazolium Salts,
http://linkedlifedata.com/resource/pubmed/chemical/vanillin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1521-0111
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
75
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
151-7
|
pubmed:meshHeading |
pubmed-meshheading:18835982-Benzaldehydes,
pubmed-meshheading:18835982-Carcinoma, Hepatocellular,
pubmed-meshheading:18835982-Cell Line, Tumor,
pubmed-meshheading:18835982-Dose-Response Relationship, Drug,
pubmed-meshheading:18835982-Down-Regulation,
pubmed-meshheading:18835982-Formazans,
pubmed-meshheading:18835982-Genes, Reporter,
pubmed-meshheading:18835982-Humans,
pubmed-meshheading:18835982-Liver Neoplasms,
pubmed-meshheading:18835982-Luciferases,
pubmed-meshheading:18835982-Matrix Metalloproteinase 9,
pubmed-meshheading:18835982-Models, Biological,
pubmed-meshheading:18835982-NF-kappa B,
pubmed-meshheading:18835982-RNA, Messenger,
pubmed-meshheading:18835982-Signal Transduction,
pubmed-meshheading:18835982-Tetrazolium Salts
|
pubmed:year |
2009
|
pubmed:articleTitle |
Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-kappaB signaling pathway in human hepatocellular carcinoma cells.
|
pubmed:affiliation |
Department of Radiation Therapy and Oncology, China Medical University Hospital, Taichung, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|